Welcome to NRG Oncology!

Welcome to the NRG Oncology Web site! This resource serves to provide current information about NRG Oncology’s exciting research future and the latest updates about plans to support our clinical trial endeavors. We invite you to check back often to learn “what’s new.”

Who We Are

NRG Oncology brings together the unique and complementary research areas of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). NRG Oncology builds upon our more than 150 years of cumulative research experience to conduct practice defining, multi-institutional clinical trials resulting in the improved survival and quality of life of patients with cancer. NRG Oncology has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).


NRG Oncology is proud to be an active participant of Cancer Moonshot.




Learn about the leaders and plans for NRG Oncology's NCORP Research Base.


NRG Oncology
Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103
Contact Us

To receive the NRG Oncology Newsletter and occasional eNews announcements and press releases, please click on the link to complete the request form.

Powered by Benchmark Email

What’s New

Let us know how our Communications Committee is doing! Fill out our survey to provide us with feedback regarding NRG Oncology's newsletter, website, and other communications. Read more

Thomas B. Julian, MD, named an NRG Oncology deputy chair, chair of the NRG Oncology Communications Committee and co-chair of the NRG Oncology Publications Committee. Read more

Walter J. Curran Jr., MD, a NRG Oncology Group Chair, was recently interviewed regarding adjuvant temozolomide in elderly patients with glioblastoma at ASCO. Read more 

NRG Oncology Group Chair Dr. Wolmark nominated for Giants of Cancer Care® award Read more

RTOG 0617 Shows Survival Correlation for Low versus High Enrolling Institutions for Patients with LA-NSCLC. Read more

NRG Oncology at ASCO 2016. Read more

Promising survival outcomes for primary CNS lymphoma patients treated with Rituximab, Chemotherapy, and Radiation. Read more

GOG-0237 Study News.  Read more ​

NRG Oncology Group Chair Dr. Curran receives ACR Gold Medal Award.  Read more ​

Dr. George named chair of NRG Oncology Colorectal Cancer Committee.

NRG RTOG 9802 shows increased survival for low-grade glial brain tumors in NEJM publication.  Read more 

NRG RTOG 0415 reports benefit of shortened RT schedule for low-risk prostate cancer patients.  Read more 

Dr. Wolmark's SABCS presentation available to view online. Read more

Dr. Ganz to receive ASCO's Inaugural Joseph V. Simone Award and Lecture.  Read more

Referral of Patients with pleuropulmonary blastoma (PPB) and PPB-associated tumors (cystic nephroma, Sertoli-Leydig cell tumors and other sex dord-stromal tumors).  Read more

Dr. Wolmark to receive McGuire Memorial Lectureship award at SABCS.  Read more

Twenty-three NRG Oncology presentations were featured at ASTRO 2015 including two plenary session presentations. Read more 

Walter J. Curran, Jr., MD, an NRG Oncology Chair and one of Jimmy Carter's treating physicians at the Winship Cancer Institute of Emory University, was interviewed for the article "Treating Jimmy Carter's Cancer" that appeared in the August 24 edition of The Atlantic Journal-Constitution. Link to article

NRG Oncology Science at the 2015 ASCO Annual Meeting

Postmenopausal women treated for ductal carcinoma in situ breast cancer gain significant benefit from treatment with anastrazole compared with tamoxifen. Read more


Copyright 2016 by NRG Oncology